Browsing Category
Healthcare
Newcastle Takeaway Ban Tackles Obesity Crisis as UK Economy Struggles
In a bold move to combat soaring obesity rates, Newcastle upon Tyne, the birthplace of the iconic Greggs bakery chain, has implemented a ban on new takeaway and fast food openings.
The city council's decision comes amidst complaints that…
The Isle of Wight Reveals Britains Looming Adult Social Care Crisis
As Britain's population grows older and sicker, the demand for adult social care is spiralling out of control. Nowhere is this more evident than on the Isle of Wight, where the local authority spends more per head – around £630 in 2022/23 –…
Assura Acquires £500M Private Hospital Portfolio Amidst NHS Waiting List Crisis
The ongoing NHS waiting list crisis has led to a surge in demand for private healthcare services in the UK. Assura, a prominent healthcare property investor and developer, has capitalised on this trend by acquiring a portfolio of 14 private…
Eli Lilly’s Weight-Loss Drug Zepbound Surpasses $1bn in Sales, Beating Expectations
In a remarkable feat, Eli Lilly's weight-loss drug Zepbound has surpassed 1 billion in sales for the first time, exceeding Wall Street's expectations. The American pharmaceutical giant also saw strong demand for its diabetes and weight-loss…
ONS: UK post-pandemic recovery higher than previously thought
According to updated data, which gives more weight to healthcare and energy industries, the UK economy has recovered from the Covid-19 epidemic in a better state than was previously believed.
Office for National Statistics has now…
NHS Budget Cuts Leave Newly Qualified Nurses Struggling to Find Jobs
The NHS is facing a troubling situation as newly qualified nurses are finding it increasingly difficult to secure entrance-level positions due to budget cuts forcing the organisation to reduce vacancies by a staggering 25%. This revelation,…
AI Breakthrough: Predicting Bowel Cancer Recurrence and Optimising Treatment
In a groundbreaking study, researchers from the University of Leeds have harnessed the power of artificial intelligence (AI) to identify early-stage bowel cancer patients at the highest risk of disease recurrence. This innovative approach…
NHS Approves Ground-Breaking At-Home Blood Cancer Treatment
In a significant development for blood cancer patients in England, the NHS has announced the approval of zanubrutinib, a revolutionary 'take-at-home' tablet for treating marginal zone lymphoma (MZL). This milestone marks the first time an…
UK’s First Paediatric Robotic Surgery Paves Way for Minimally Invasive Procedures
In a groundbreaking medical development, a seven-year-old boy from Gosport, Hampshire, has become the first patient in the United Kingdom to undergo robotic surgery for a kidney condition. Reece Wilton underwent the pioneering operation at…
Wes Streeting: NHS should “seek to utilize” private healthcare capacity
Wes Streeting, the shadow health secretary, has stated that he would like the NHS to rely on the private sector for the short-term so it can reduce its dependency in the future. He also rejected New Labour’s "ideological belief" that…
Rare genetic disease treatment becomes the world’s most costly drug at $4.25mn
In the US, a new gene therapy that treats a rare genetic disorder that attacks the nervous system central of young children is priced at $4.25mn. This makes it the most costly drug in history.
Lenmeldy, a medicine developed by Orchard…
Indivior’s US moves gets closer as major investors will not oppose the move
Indivior's top shareholder -- one of the largest institutional investors in the City -- is unlikely oppose its plans to move to the United States.
Indivior, a company that specializes in treating substance abuse disorders and serious…
AstraZeneca acquires next-generation cancer treatments
The largest British pharmaceutical group has acquired a Canadian firm that is developing the next generation of cancer treatments. This is its second acquisition this week, aimed at boosting its drug pipeline.
AstraZeneca is accelerating…
Pfizer begins to reduce its stake in Haleon
Pfizer is selling a stake of its former joint venture in consumer healthcare, Haleon. The sale will be worth approximately £2.3 billion.
The American drug company intends to reduce its remaining holdings in the manufacturer of Sensodyne…
AstraZeneca purchases rare diseases group in order to boost drug pipeline
The largest pharmaceutical company in Britain has signed a deal to buy a French company that specializes in rare diseases for more than $1 billion. This is part of its efforts to boost the pipeline of drugs.
AstraZeneca agreed to…
Halma becomes cervical cancer specialist
Halma has acquired a company which makes devices for early detection and prevention cervical cancer.
The FTSE 100 manufacturer of health and safety products has reached an agreement for Rovers Medical Devices to receive up to €91m.…
Data shows that expired Pfizer Covid antiviral medications will cost Europe $2.2bn.
According to data from the European Health Agency, more than one billion dollars of Pfizer Covid-19 antiviral medications procured by Pfizer in Europe were wasted because strict controls on who could receive the medication led to millions…
The boom in private health insurance exposes its own flaws
The demand for private medical insurance has soared. Unprecedented waiting lists in the UK NHS, and a crisis within primary care in the country have pushed it to its highest level in many years. The surge in demand poses problems for both…